{"id": "1253035118429704195", "author_id": "963495628545327104", "text": "$ABBV $JNJ NEW ARTICLE : Johnson &amp; Johnson and AbbVie Earn a New FDA Approval for Imbruvica https://t.co/hMmYUsEfC3 Get all the latest $ABBV related news here : https://t.co/dELsGS3Ir2 https://t.co/OBJeKzjGUc", "created_at": "2020-04-22T18:57:07.000Z"}
{"id": "1253068230488403979", "author_id": "314281991", "text": "RT @biopharma_cg: $MYOV This is extremely strong data. If I were on $ABBV's Orilissa brand team, I would be pretty worried about right now.\u2026", "created_at": "2020-04-22T21:08:41.000Z"}
{"author_id": "1271595955", "id": "1252891581977227264", "text": "RT @syinvesting: Takeaways from @evaluatepharma Orphan Drug Report 2020:\n\n- Orphan drug sales: $119B (2018) \u2192 $217B (2024)\n- Top companies:\u2026", "created_at": "2020-04-22T09:26:45.000Z"}
{"author_id": "120743106", "id": "1252925761956257793", "text": "RT @apbiomed: Regarding the $MYOV relugolix SPIRIT 2 data tomorrow, here are the elagolix data from the $ABBV ELARIS trials for reference.\u2026", "created_at": "2020-04-22T11:42:34.000Z"}
